IGF2 and colorectal carcinoma: Specifically, in this region, IGF2 overexpression was found to be caused by hypomethylation, which acts as a risk biomarker for colorectal carcinoma due to its implication in tumorigenesis promotion [28], as well as in different stages of progression and metastasis [29].